Share

CRC 2011 organisation and implementation of cancer clinical and trials

The primary intent of this website is the communication of clinical cancer research with oncologists and health professionals in the field, but it is recognized that the information presented here might also be of interest to patients, charities, funding organizations and the general public.

 

 

 

 

 

 

 

 

 

Back to news list

Related News

  • Multinational study provides new evidence for the value of response-adapted, personalised treatment in Hodgkin lymphoma

  • EORTC’s presence at ESTRO 2026

  • Interview of ROSC Chair, Joost Vaerhoeff

  • Independent, academic cancer trials are vital to improve patient outcomes worldwide

  • EORTC Imaging Group Becomes the Diagnostic and Therapeutic Imaging Group

  • Investing in the future of cancer research; EORTC’s Young and Early Career investigator Network shows its value

  • In Memoriam of Martine Van Glabbeke (1951-2026)

  • PEACE-3 trial demonstrates significant overall survival benefit in patients with metastatic castration-resistant prostate cancer with bone metastases

  • EORTC celebrates Rare Disease Day: Addressing unmet needs in rare cancers

  • First Site Activated in EORTC RENALUT Clinical Trial on Metastatic Clear Cell Renal Cell Carcinoma